Beta Bionics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeBeta Bionics
Beta Bionics logo

Beta Bionics

0 followers

BBNX

Performance

About Beta Bionics

Beta Bionics develops the iLet Bionic Pancreas, an automated insulin delivery system designed for people with type 1 diabetes. The device uses data from Dexcom CGMs or FreeStyle Libre 3 Plus sensors to automate insulin dosing, aiming to reduce user decision-making in diabetes management. The company targets both adults and children, provides resources for healthcare professionals, and emphasizes patient-centered diabetes technology innovation with global reach.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Douglas Ferguson

VP, of Clinical & Regulatory Affairs

Mark Hopman, R.Ph, MBA

Chief Commercial Officer

Himanshu Patel

VP, Research & Development

David Henderson

VP, Operations

Tony Galliani

VP, Commercial Strategy

Key Facts

HQ Location

Concord, United States

Founded

2015

Employees

201 - 500

Status

Public

Website

https://betabionics.com